

Cover Story
Free
By Matthew Bin Han Ong
Friends call him The Hoomanator, a darkly comical conflation of his first name, Hooman, and morcellator, the medical device he has aggressively campaigned against.
In Brief


Drugs & Targets
Trending Stories
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- Why both somatic and germline genomic profiling are essential for precision oncology